Related Experiment Video
Updated: May 20, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis
Fabio Forghieri1, Mario Luppi, Patrizia Barozzi
1Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy.
Insights
Chronic Hepatitis C virus (HCV) infection is linked to B-cell non-Hodgkin's lymphomas (B-NHL). Research explores multifactorial mechanisms in HCV-associated lymphomagenesis, suggesting combined biological factors contribute to cancer development.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatitis C virus (HCV) is a prevalent chronic infection affecting 180 million globally.
- Extrahepatic manifestations are common in chronic HCV, including B-cell non-Hodgkin's lymphomas (B-NHL).
- Antiviral therapy shows efficacy in treating some HCV-associated lymphoproliferative disorders, indicating an etiopathogenetic link.
Purpose of the Study:
- To elucidate the mechanisms by which HCV induces B-cell lymphoproliferation.
- To investigate the multifactorial model of HCV-associated lymphomagenesis.
Main Methods:
- Review of epidemiological and clinical evidence.
- Hypothesizing biological mechanisms involved in lymphomagenesis.
Main Results:
- A correlation between chronic HCV infection and B-NHL occurrence is established.
- Antiviral therapy effectiveness suggests a direct role of HCV in lymphomagenesis.
- Proposed mechanisms include chronic antigen stimulation, HCV-E2 protein interactions, direct B-cell infection, and "hit and run" events.
Conclusions:
- The precise mechanisms of HCV-induced B-cell lymphoproliferation remain under investigation.
- A multifactorial model involving combined biological mechanisms is proposed for HCV-associated lymphomagenesis.
Abstract:
Hepatitis C virus (HCV) infection is probably the most common chronic viral infection and affects an estimated 180 million people worldwide, accounting for 3% of the global population. Although the liver is considered to be the primary target, extrahepatic manifestations are well recognized among patients with chronic HCV infection. Epidemiological studies have clearly demonstrated a correlation between chronic HCV infection and occurrence of B-cell non-Hodgkin's lymphomas (B-NHL). The clinical evidence that antiviral therapy has a significant role in the treatment at least of some HCV-associated lymphoproliferative disorders, especially indolent B-NHL, further supports the existence of an etiopathogenetic link. However, the mechanisms exploited by HCV to induce B-cell lymphoproliferation have so far not completely clarified. It is conceivable that different biological mechanisms, namely, chronic antigen stimulation, high-affinity interaction between HCV-E2 protein and its cellular receptors, direct HCV infection of B-cells, and "hit and run" transforming events, may be combined themselves and cooperate in a multifactorial model of HCV-associated lymphomagenesis.
Related Concept Videos
Hepatitis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cytomegalovirus Disease
Cirrhosis II: Pathophysiology

